---
source_pdf: "https://drive.google.com/file/d/1aPPK8dkiAcsXvIXAB69Vf5LgxH5zNlxd/view"
drive_folder: "Research"
type: research

ingested: 2025-12-27
original_filename: "Medscout Deck (2).pdf"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1aPPK8dkiAcsXvIXAB69Vf5LgxH5zNlxd/view)

## Slide 1: MedScout Title Slide

MedScout
Revenue Acceleration Built for
Life Science Companies

## Slide 2: EXECUTIVE SUMMARY - MedScout has found PMF and is at an inflection point

**EXECUTIVE SUMMARY**
MedScout has found PMF and is at an inflection point

*   $745k in ARR (<18 months in market)
*   $1.2m+ run rate for 1st sales rep (Q1 '23)
*   21% average MoM growth (Jan '22 - Mar '23)
*   20+ referenceable customers

*   MedScout has uncovered how to uniquely enable reps selling into healthcare.
*   Addressing a major market void and customer pain points left by a large incumbent.
*   Rapidly taking market share and are well positioned to continue growing quickly.
*   Raising $3m-$4m to scale the team and platform to support our pipeline.

MedScout Proprietary & Confidential | 2

## Slide 3: PROBLEM - Life science companies struggle to enable their commercial teams & evolve their sales motion

**PROBLEM**
Life science companies struggle to enable their commercial teams & evolve their sales motion

*   Funnel management and improvement is too intensive for reps
*   Sales leadership doesn't have the visibility to effectively forecast, plan, and coach
*   Marketing is disconnected from the field sales motion

MedScout Proprietary & Confidential | 3

## Slide 4: PROBLEM - Current enablement platforms are not built to address their unique combination of needs

**PROBLEM**
Current enablement platforms are not built to address their unique combination of needs

**Unique Painpoints**
*   **X** Low digital buying signals & inbound demand
*   **X** Difficult to qualify prospects
*   **X** Pipeline largely worked in-person
*   **X** Complex and fluid buying ecosystems

**Vertical Requirements**
*   Account-based sales targeting
*   Deep, medical-specific market intelligence
*   In-person process accommodation

MedScout Proprietary & Confidential | 4

## Slide 5: AS A RESULT - Medtech companies spend up to 3X more on SG&A expenses than other tech companies

**AS A RESULT**
Medtech companies spend up to 3X more on SG&A expenses than other tech companies

Source: BCG 2021 The Rise of the Next Generation of Medtech Milkmen
MedScout Proprietary & Confidential

## Slide 6: SOLUTION - MedScout - Purposefully designed to seamlessly integrate and accelerate the medical sales motion

**SOLUTION**
MedScout
Purposefully designed to seamlessly integrate and accelerate the medical sales motion

*   **Map**
    Optimize Territories
    *(Image: Map interface showing prospect locations)*
*   **Plan**
    Identify Ideal Targets
    *(Image: List of prospects with details)*
*   **Execute**
    Empower Your Team
    *(Image: Mobile interface displaying prospect information)*
*   **Evolve**
    Track Performance
    *(Image: Dashboard showing rep performance metrics)*

**Rep Performance Data (from "Evolve" section image):**

| Rep Name          | Created | Closed Won | Closed Lost | Progressed | Regressed | No Movement |
| :---------------- | :------ | :--------- | :---------- | :--------- | :-------- | :---------- |
| Alexandra Frank   | 11 +15% | 6 +10%     | 1 +100%     | 8 +12%     | 0 -0%     | 3 -5%       |
| Mark Haas         | 8 +3%   | 12 +23%    | 2 +100%     | 1 +8%      | 1 +4%     | 2 -0%       |
| Timothy Sanchez   | 9 +2%   | 5 +10%     | 0 -0%       | 5 +8%      | 1 +8%     | 2 +8%       |
| Joy Lindquist     | 3 +12%  | 3 +19%     | 1 +100%     | 4 -0%      | 0 -6%     | 3 -0%       |
| Jason Fitzgerald  | 4 +14%  | 4 +8%      | 1 -0%       | 1 +10%     | 1 +4%     | 1 -0%       |
| Kelly Gordon      | 5 +1%   | 8 +42%     | 0 -0%       | 5 +8%      | 1 -0%     | 0 -0%       |
| Anthony Vitto     | 4 +0%   | 5 +12%     | 0 -0%       | 3 +8%      | 2 +10%    | 2 -0%       |
| Sam Scheer        | 13 +6%  | 9 +8%      | 0 -0%       | 0 +8%      | 1 +4%     | 1 -0%       |

Q4 Focus: 39 Prospects, Justin Schaffer, Thoracic Surgery (Cardiothoracic Surgery)

MedScout Proprietary & Confidential | 6

## Slide 7: OPPORTUNITY - Platforming healthcare sales & marketing is a massive opportunity

**OPPORTUNITY**
Platforming healthcare sales & marketing is a massive opportunity

**Bottoms Up Market Assessment**
$5.8 billion / year

**Public Comparable**
Definitive Healthcare
*   $1.3b Market Cap, $208m Trailing Twelve Months Revenue
*   Estimates market @ $10b+/year

**We're starting here**
9,414 companies
*   US-Based Medical Device and Diagnostics companies

**And moving into these markets next**
~ 120,000 companies
*   Home Health
*   Pharma (manufacturers and distributors)
*   Digital Health / Healthcare Software
*   Healthcare services firms (consulting, staffing, etc.)
*   Hospitals / Surgery Centers / Physicians

MedScout Proprietary & Confidential | Source: Linkedin Sales Navigator, DHC S-1 | 7

## Slide 8: CURRENT GTM - We've built material momentum in a short period of time in-market

**CURRENT GTM**
We've built material momentum in a short period of time in-market

**By the numbers**
*   $745k in ARR, 28 active customers
*   21% AVG MoM ARR growth with one AE (joined April '22) and minimal marketing
*   1.0 average burn multiple (trailing 3 months)
*   6 week median sales cycle
*   127% Net Dollar Retention

**ARR (Historical and Projections)**

| Period | ARR (US$)    | AVG ACV |
| :----- | :----------- | :------ |
| H1 '22 | 196,000      | $15k    |
| H2 '22 | 361,000      | $26k    |
| H1 '23 | 900,000      | $36k    |
| H2 '23 | 1,400,000    |         |
| H1 '24 | 2,200,000    |         |
| H2 '24 | 3,400,000    |         |

MedScout Proprietary & Confidential | 8

## Slide 9: CURRENT GTM - In Q3 of 2022, we enabled step-change in growth

**CURRENT GTM**
In Q3 of 2022, we enabled step-change in growth

"...when will you have commercial claims?"
*   Negotiated an exclusive rev-share deal with a leading claims analytics provider

"..how does this integrate with my CRM?"
*   Built integrations with Salesforce, Hubspot, and MSFT Dynamics

MedScout Proprietary & Confidential | 9

## Slide 10: CURRENT GTM - We're winning now competitive deals regularly and the Enterprise pipeline is building

**CURRENT GTM**
We're winning now competitive deals regularly and the Enterprise pipeline is building

**Why we win**
MedScout vs. DEFINITIVE HEALTHCARE
*   Superior user experience
*   Streamlined CRM integrations
*   Better-fit licensing & pricing

MedScout vs. acuityDX
*   Superior user experience
*   Value prop that enables quick sales cycle and adoption
*   Better data

**Recent competitive wins**
*   CoreLink.
    $32k yr
    win over DHC
*   CHANNEL MEDSYSTEMS
    $32k yr
    win over DHC
*   EndoGastric Solutions®
    $69k yr
    win over Acuity
*   CapsoVision
    $39k yr
    win over Acuity

**Enterprise prospects ($100k/year+) in pipeline**
*   PHILIPS
*   enovis™
*   HeartFlow
*   iRHYTHM
*   AVANOS
*   angiodynamics

MedScout Proprietary & Confidential | 10

## Slide 11: ROADMAP - Our roadmap will continue to drive differentiation, defensibility, and pricing leverage

**ROADMAP**
Our roadmap will continue to drive differentiation, defensibility, and pricing leverage

*   **Connect w/ CRMs (Completed)**
    *   Salesforce logo
    *   HubSpot logo
    *   Microsoft Dynamics CRM logo
    *(Image of MedScout interface integrated with CRM data)*
*   **Deliver unique pipeline insights (Testing)**
    *(Image of MedScout interface with pipeline data)*
*   **Programmatic "Next Best Actions"**
    *(Illustrative flow diagram)*
*   **Territory modeling and leakage analysis**
    *(Image of MedScout map interface with territory analysis)*

MedScout Proprietary & Confidential | 11

## Slide 12: LONG-TERM VISION - We're well positioned to become the must-have platform for selling into healthcare

**LONG-TERM VISION**
We're well positioned to become the must-have platform for selling into healthcare

**Solving sales and territory planning wedge**
*   Territory design and evolution
    *(Image of map interface)*
*   Pipeline generation, execution, and inspection
    *(Image of list interface)*
*   CRM augmentation and commercial stack integration
    *(Image of CRM icon)*

**Unlocks other use-cases and additional wallet share**
*   \+ $$$ Content distribution/analytics
*   \+ $$$ Forecasting / Commissioning
*   \+ $$ Clinical Ops / Inventory
*   \+ $$ Sales expense management
*   \+ $$ Systems Integration
*   \+ $ CPQ workflows

MedScout Proprietary & Confidential | 12

## Slide 13: STRATEGY - We have a plan to execute on a multi-billion $ opportunity

**STRATEGY**
We have a plan to execute on a multi-billion $ opportunity

**Seed to Series A**
*   Ent
*   Mid-market
*   Long-tail
*   Device and diagnostics
*   Own Mid-market via outbound
*   Mature to Enterprise
*   Start to build Demand Gen

**Series A to B**
*   Ent
*   Mid-market
*   Expansion verticals
*   Long-tail
*   Device and diagnostics
*   Materially move into Enterprise
*   Start to convert long-tail
*   Test other verticals

**Series B+**
*   Ent
*   Mid-market
*   Expansion verticals
    *   Home Health
    *   Pharma
    *   Digital Health
    *   Healthcare Services
    *   Hospitals/Surgery Centers/Physicians
*   Long-tail
*   Device and diagnostics
*   Own device and diagnostics top to bottom
*   Expand use cases to capture more wallet
*   Expand into other verticals

MedScout Proprietary & Confidential | 13

## Slide 14: LEADERSHIP - We have the skillsets and industry knowledge needed to execute

**LEADERSHIP**
We have the skillsets and industry knowledge needed to execute

**LEADERSHIP TEAM**
*   *(Photo)*
    Skylar Talley
    Co-Founder & CEO
*   *(Photo)*
    Casey Shattuck
    Co-Founder & CTO
*   *(Photo)*
    Mark Mescher
    VP of Sales
*   *(Photo)*
    Marcus Motill
    Lead Architect

**INDUSTRY ADVISORS**
*   *(Photo)*
    Casey Shattuck Sr
    Life Science Executive
*   *(Photo)*
    J. Scott Heinzelman
    Life Science Executive
*   *(Photo)*
    Lisa Bichsel
    Life Science Executive
*   *(Photo)*
    Paul Edwards
    Life Science Executive
*   *(Photo)*
    Charlie Whelan
    SR. VP
    Frost and Sullivan Healthcare
*   *(Photo)*
    Michael Moore
    Founder
    M.J. Moore & Associates, Inc.

MedScout Proprietary & Confidential | 14

## Slide 15: CAPITAL PLAN - We need capital to add headcount and continue building momentum towards our next milestones

**CAPITAL PLAN**
We need capital to add headcount and continue building momentum towards our next milestones

**Next Milestones**
*   Scale Sales and build Marketing function
*   Scale Product and Ops to support the Enterprise segment
*   $3m in ARR by EOY '24

**12-month Hiring Plan**

**Phase 1**
*   Backend Engineer
*   Onboarding and Support Specialist
*   Marketing Lead

**Phase 2**
*   Design Lead
*   Front-end #2
*   Product Lead
*   Account Exec #2
*   Account Exec #3

MedScout Proprietary & Confidential | 15

## Slide 16: MedScout contact information

MedScout
skylar@medscout.io
903.521.3237

MedScout Proprietary & Confidential | 16